Bioceres Crop Solutions Corp.

NasdaqGS:BIOX Stock Report

Market Cap: US$750.2m

Bioceres Crop Solutions Management

Management criteria checks 3/4

Bioceres Crop Solutions' CEO is Federico Trucco, appointed in Jun 2011, has a tenure of 12.83 years. directly owns 0.66% of the company’s shares, worth $4.94M. The average tenure of the management team and the board of directors is 7.5 years and 5.1 years respectively.

Key information

Federico Trucco

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure12.8yrs
CEO ownership0.7%
Management average tenure7.5yrs
Board average tenure5.1yrs

Recent management updates

Recent updates

Bioceres Needs To Add Clarity Around Borrowings

Mar 23

Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Feb 03
Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Oct 04
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Jun 21
Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

May 09
Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

Bioceres: A Resilient Small Cap With Conference Appearances After Thursday's Earnings

Sep 06

Bioceres Crop Solutions jumps 15% after investor pitch

Aug 23

We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Apr 10
We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Bioceres Has Not Resolved Its Major Risks And Is Growing Based On Commodities Bullishness

Mar 31

Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Mar 17
Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Nov 13
Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Jul 08
Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Jun 16
Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

May 26
What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

Bioceres partners with Havanna to offer consumers HB4 wheat-based sustainable products

May 10

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

May 05
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Apr 05
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Mar 10
Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Feb 12
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

CEO Compensation Analysis

How has Federico Trucco's remuneration changed compared to Bioceres Crop Solutions's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

US$22m

Sep 30 2023n/an/a

US$14m

Jun 30 2023n/an/a

US$19m

Mar 31 2023n/an/a

US$15m

Dec 31 2022n/an/a

-US$19m

Sep 30 2022n/an/a

-US$8m

Jun 30 2022n/an/a

-US$7m

Mar 31 2022n/an/a

-US$2m

Dec 31 2021n/an/a

US$4m

Sep 30 2021n/an/a

US$976k

Jun 30 2021US$659kUS$131k

-US$7m

Mar 31 2021n/an/a

-US$5m

Dec 31 2020n/an/a

-US$7m

Sep 30 2020n/an/a

US$3m

Jun 30 2020US$145kUS$145k

US$3m

Mar 31 2020n/an/a

US$20k

Dec 31 2019n/an/a

-US$18m

Sep 30 2019n/an/a

-US$23m

Jun 30 2019US$155kUS$155k

-US$18m

Mar 31 2019n/an/a

-US$26m

Dec 31 2018n/an/a

-US$8m

Sep 30 2018n/an/a

-US$13m

Jun 30 2018US$124kUS$124k

-US$11m

Compensation vs Market: Insufficient data to establish whether Federico's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Federico's compensation has been consistent with company performance over the past year.


CEO

Federico Trucco (46 yo)

12.8yrs

Tenure

US$659,418

Compensation

Dr. Federico Trucco, Ph D., has been Chief Executive Officer of Bioceres Crop Solutions Corp. since June 2011 and serves as its Chairman and serves as its Executive Director. He is Head Director of Rizobac...


Leadership Team

NamePositionTenureCompensationOwnership
Jose Roque
General Counselno dataUS$156.00kno data
Alex Garcia
Managing Director of Seedsno dataUS$94.80kno data
Federico Trucco
Executive Chairman & CEO12.8yrsUS$659.42k0.66%
$ 4.9m
Enrique López Lecube
CFO & Executive Director6.4yrsUS$372.22k0.43%
$ 3.2m
Jorge Wagner
Chief Operating Officer7.5yrsUS$345.07kno data
Paula Savanti
Head of Investor Relationsno datano datano data
Gloria Estrada
Executive Directorno dataUS$159.58k0.26%
$ 2.0m
Ricardo Yapur
Managing Director of Latam Unit & Chief Commercial Officer10.4yrsUS$405.41kno data
Matti Tiainen
Managing Director of North America & Europe1.8yrsno datano data

7.5yrs

Average Tenure

49yo

Average Age

Experienced Management: BIOX's management team is seasoned and experienced (7.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Federico Trucco
Executive Chairman & CEO5.2yrsUS$659.42k0.66%
$ 4.9m
Enrique López Lecube
CFO & Executive Director5.2yrsUS$372.22k0.43%
$ 3.2m
Gloria Estrada
Executive Director5.1yrsUS$159.58k0.26%
$ 2.0m
Keith McGovern
Non-Executive Director1.8yrsno datano data
Yogesh Mago
Non-Executive Director1.8yrsno data0.088%
$ 661.5k
Natalia Zang
Independent Non-Executive Director5.2yrsno datano data
Ari Freisinger
Independent Non-Executive Director5.1yrsno data0.099%
$ 746.0k

5.1yrs

Average Tenure

46yo

Average Age

Experienced Board: BIOX's board of directors are considered experienced (5.1 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.